Biomarker

A white blood cell, the TREM2/APOE/C1Q-positive macrophage, has been identified as a potential biomarker to predict recurrence of the most common type of kidney cancer and as a possible target for drug development. Read More

Changes in connectivity in the brain’s white matter may be a novel neuroimaging biomarker for assessing Alzheimer’s disease progression. Read More

An international group of researchers including Vanderbilt epidemiologists has identified new DNA methylation biomarkers associated with prostate cancer risk. Read More

An analysis of more than 140,000 people of European ancestry has identified blood protein biomarkers associated with prostate cancer risk. Read More

Vanderbilt researchers have identified biomarkers that could be useful for evaluating and treating pregnancy-related heart failure. Read More

Biomarker tests that help determine which patients may benefit from molecularly targeted therapies need better evidence and oversight to improve their effectiveness and availability, according to a study by the Institute of Medicine (IOM) of the National Academies of Sciences, Engineering, and Medicine. Read More

Vanderbilt investigators have identified a new biomarker to assess platelet function. Read More

A new marker could be useful for diagnosing and treating neuroendocrine tumors of the small intestines. Read More

It may be possible to use skin cells as biomarkers to diagnose and manage depression. Read More

After 40 years in basic science working with yeast cells, Nobel laureate Lee Hartwell, Ph.D., has turned his attention in a new direction. Read More

The protein TIP-1 appears to be a novel prognostic marker for glioblastoma and may be a good therapeutic target for disrupting tumor-driven blood vessel development. Read More

Archived tissue samples are yielding new disease biomarkers. Read More

A combination of biomarkers may reveal new clues about causes of and potential interventions for autism. Read More

A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer. Read More